Rituximab in pemphigus and pemphigoid patients: Treatment outcomes and safety profile - A 6-year tertiary center study. (2025). Asian Journal of Medical Sciences, 16(7), 87-91. https://www.nepjol.info/index.php/AJMS/article/view/79086